STOCK TITAN

Pacira BioSciences to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

PACIRA BIOSCIENCES, INC. (NASDAQ: PCRX) will present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on May 20, 2020, at 9:45 AM ET. Interested parties can access a live audio stream on the company's website, with a replay available for two weeks post-event. Pacira is dedicated to non-opioid pain management technologies, including its long-acting local analgesic EXPAREL®, which launched in 2012. The company also acquired the iovera⁰ cryoanalgesia device in April 2019, aiming to enhance pain management and reduce opioid reliance.

Positive
  • None.
Negative
  • None.

PARSIPPANY, N.J., May 13, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference at 9:45 AM ET on Wednesday, May 20, 2020. Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcast will also be available for two weeks following the event.

About Pacira                                                                           

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.  In April 2019, the company acquired the iovera⁰ system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

FAQ

When will Pacira BioSciences present at the RBC Capital Markets Global Healthcare Virtual Conference?

Pacira BioSciences will present on May 20, 2020, at 9:45 AM ET.

How can I access the live audio of Pacira's presentation?

The live audio can be accessed by visiting the 'Events' page on Pacira's website.

What products does Pacira BioSciences offer?

Pacira offers non-opioid pain management solutions, including EXPAREL® and the iovera⁰ cryoanalgesia device.

What is EXPAREL® and when was it launched?

EXPAREL® is a long-acting local analgesic launched in April 2012.

What is the iovera⁰ system that Pacira acquired?

The iovera⁰ system is a handheld cryoanalgesia device for targeted nerve pain relief, acquired by Pacira in April 2019.

Pacira Biosciences Inc

NASDAQ:PCRX

PCRX Rankings

PCRX Latest News

PCRX Stock Data

1.19B
44.51M
2.15%
113.85%
11.79%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
TAMPA